FIELD: molecular biology, medicine, oncology.
SUBSTANCE: invention relates to development of methods for specific biotherapy of leucosis Ph+. Method involves treatment of suspension cultures of cells Ph+ with anti-sense oligonucleotides of length 16-26 nucleotide links that are specific to mRNA of oncogen BCR/ABL in combination with anti-sense oligonucleotides to mRNA of other genes blocking apoptosis of cells Ph+ distinctive from BCR/ABL. Invention provides the development of the experimental basis for carrying out oligonucleotide genetic therapy of leucosis Ph+.
EFFECT: improved induction method.
5 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR QUANTITATIVE DETERMINATION OF G250E MUTATION OF BCR-ABL KINASE DOMAIN FOR PATIENTS WITH CHRONIC MYELOID LEUKOSIS RESISTANT TO THYROSINKINASE INHIBITORS THERAPY | 2016 |
|
RU2620076C1 |
AGENT AND METHOD FOR APOPTOSIS INDUCTION IN CANCER CELLS | 2012 |
|
RU2488408C1 |
USE OF COMPOSITION OF COPPER OXIDE NANOPARTICLES AND N-ACETYLCYSTEINE FOR DEATH INDUCTION OF CELLS OF CHRONIC MYELOID LEUKAEMIA | 2019 |
|
RU2721771C1 |
METHOD OF ESTIMATION OF INFLUENCE OF NITROSAMINES ON APOPTOSIS IN CHILDREN LIVING IN ADVERSE ENVIRONMENTAL CONDITIONS | 2016 |
|
RU2626516C1 |
METHOD FOR QUANTITATIVE DETERMINATION OF MUTATIONS F317L AND F359V/C OF THE KINASE DOMAIN BCR-ABL IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA RESISTANT TO THERAPY WITH TYROSINE KINASE INHIBITORS | 2019 |
|
RU2698461C1 |
METHOD OF INDUCING APOPTOSIS OF MALIGNANT TUMOUR CELLS OF COLORECTAL CANCER AND MEANS FOR ITS REALISATION | 2013 |
|
RU2551238C9 |
ANTI-IL1RAP ANTIBODIES AND THEIR USE FOR TREATING HUMAN | 2012 |
|
RU2597831C2 |
ANTIBODY SELECTIVE TO RECEPTOR APOPTOSIS-INDUCING LIGAND AND ASSOCIATED WITH TUMOR NECROSIS FACTOR AND ITS USING | 2002 |
|
RU2313537C2 |
METHOD OF OPTIMISING THERAPY OF PHILADELPHIA CHROMOSOME POSITIVE LEUKAEMIA BY Ab1-TYROSINE KINASE INHIBITORS | 2007 |
|
RU2483732C2 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN CHRONIC MYELOID LEUKEMIA | 2012 |
|
RU2481583C1 |
Authors
Dates
2004-11-20—Published
2002-11-12—Filed